Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
    • Careers
    • MTR - Our diagnostics specialists with insight
Welcome to the MHH
Searched for b.v. Found 114 results in 9 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • »
Page

Work group Vital

Relevance: 77%
 

Tiede A, Conradi AM, Woltemate S, Geffers R, Bremer B, Spielmann V, Kahlhöfer J, Kraft ARM, Schlüter D, Wedemeyer H, Cornberg M, Falk C, Vital M*, Maasoumy B*. 2025. Distinct clusters of bacterial and fungal [...] Goldschmidt I, Kramer M, Junge N, Ouro-Djobo N, Poets A, Rathert M, Geffers R, Baumann U, Hartleben B, Schulze KD, Woltemate S, Vital M. 2025. Short-term and long-term development of gut microbiota in children [...] 10(1):63. Happ E, Schulze K, Afrin Z, Woltemate S, Görner P, Ziesing S, Schlüter D, Geffers R, Winstel V, Vital M. 2024. Gut microbiota-derived butyrate selectively interferes with growth of carbapenem-resistant

Page

Hans Bakker Publications

Relevance: 77%
 

Krylov,V., Ustyuzhanina,N., Grachev,A., Bakker,H., and Nifantiev,N. (2007). Stereoselective synthesis of the 3-aminopropyl glycosides of a-D-Xyl-(1 -> 3)b-D-Glc and a-D-Xyl-(1 -> 3)-a-D-Xyl-(1 -> 3)-b-D-Glc [...] , Ashikov, A., Tiemann, B., Lehle, L., and Bakker, H. (2013). C. elegans DPY-19 is a C-Mannosyltransferase Glycosylating Thrombospondin Repeats. Mol. Cell 50, 295-302. Lee, T.V. , Sethi, M.K., Leonardi [...] glycan structures as LARGE. Glycobiology 23, 303-309. Sethi,M.K. , Buettner,F.F., Ashikov,A., Krylov,V.B., Takeuchi,H., Nifantiev,N.E., Haltiwanger,R.S., Gerardy-Schahn,R., and Bakker,H. (2012). Molecular

Page

Publications

Relevance: 76%
 

Rohde M, Weiss S, Förster R. Front Immunol. 2019 May 17;10:1082. Induced B Cell Development in Adult Mice. Brennecke AM, Düber S, Roy B, Thomsen I, Garbe AI, Klawonn F, Pabst O, Kretschmer K, Weiss S. Front [...] potential of bacterial flagella for Salmonella-mediated tumor therapy. Felgner S, Spöring I, Pawar V, Kocijancic D, Preusse M, Falk C, Rohde M, Häussler S, Weiss S, Erhardt M. Int J Cancer. 2019 Nov 21 [...] flagella in acute and chronic Pseudomonas aeruginosa infections. Lorenz A, Preuße M, Bruchmann S, Pawar V, Grahl N, Pils MC, Nolan LM, Filloux A, Weiss S, Häussler S. Environ Microbiol. 2019 Mar;21(3):883-897

Page

Publications

Relevance: 76%
 

Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WH, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia [...] I, Schäffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. Nat Genet. 2007 Jan;39(1):86-92. doi: [...] families and description of a novel mutation. Savoia A, Germeshausen M, De Rocco D, Henschel B, Kratz CP, Kuhlen M, Rath B, Steuhl KP, Wermes C, Ballmaier M. Ann Hematol. 2010 Oct;89(10):1057-9. doi: 10.1007/

Page

Publications

Relevance: 76%
 

Demeer B, Lebrun M, Keren B, Nava C, Buratti J, Afenjar A, Shinawi M, Guillen Sacoto MJ, Gauthier J, Hamdan FF, Laberge AM, Campeau PM, Louie RJ, Cathey SS, Prinz I, Jorge AAL, Terhal PA, Lenhard B, Wieczorek [...] 24. [Epub ahead of print] Petermann, F., Rothhammer, V., Claussen, M. C., Haas, J. D., Blanco, L. R., Heink, S., Prinz, I., Hemmer, B., Kuchroo, V. K., Oukka, M., and Korn, T. (2010). gammadelta T cells [...] J., … Mavilio, D. (2023). Transcriptomic profile of TNFhigh MAIT cells is linked to B cell response following SARS-CoV-2 vaccination. Frontiers in immunology, 14, 1208662. https://doi.org/10.3389/fimmu

Page

Publikationen

Relevance: 76%
 

Jaroszewicz J, Bremer B, Lehmann P, Deterding K, Taranta A, Manns MP, Wedemeyer H, Glebe D, Cornberg M. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection [...] J, Oschlies I, Hussein K, Pape L, Baumann U, Tönshoff B, Pohl M, Höcker B, Wingen AM, Klapper W, Kreipe H, Schulz TF, Klein C, Maecker-Kolhoff B. EBV-specific T-cell immunity in pediatric solid organ [...] Blasczyk R, Eiz-Vesper B. Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy. Clin Exp Immunol. 2011;165(2):220-34. Leifheit-Nestler M, Richter B, Basaran M , Nespor J

Page

Publications

Relevance: 75%
 

Montag, J., Kowalski, K., Iorga, B., de la Roche, J., Holler, T., Wojciechowski, D., Wendland, M., Radocaj, A., Mayer, A. K., Brunkhorst, A., Osten, F., Burkart, V., Piep, B., Bodenschatz, A., Gibron, P. [...] Holler, T., Piep, B., Kröhn, S., Teske, J., Bodenschatz, A. K., Devadas, S. B., Menge, K. S., Chatterjee, S., Schwanke, K., Kosanke, M., Montag, J., Thum, T., Zweigerdt, R. , Kraft, T., Iorga, B., and Meissner [...] L. G., Mall, M. A., Hocke, A. C., Thiel, V., Osterrieder, K., Wolff, T., Martin, U. , Corman, V. M., Müller, M. A., Goffinet, C., and Drosten, C. 2022. SARS-CoV-2 variant Alpha has a spike-dependent replication

News

Effectiveness of the new Omikron booster confirmed

Relevance: 74%
 

against SARS-CoV2 in employees of the MHH and affiliated institutions. "Our data can also make a significant contribution to better understanding the long-term immune response against SARS-CoV-2 and assessing [...] body's own defences against the currently spreading variants "Pirola" (BA2.86) and "Eris" (EG1.5). "The B cells that produce antibodies against Omikron increased significantly and the T cells were also strengthened [...] show that the new booster vaccination achieves its goal and also induces antibodies against new SARS-CoV-2 variants." Defence in two directions Like the first coronavirus vaccines from Biontech and Moderna

Page

Publications

Relevance: 74%
 

42(10), 113230. https://doi.org/10.1016/j.celrep.2023.113230 Bošnjak, B., Henze, E., Lueder, Y., Do, K. T. H., Rezalotfi, A., Čuvalo, B., Ritter, C., Schimrock, A., Willenzon, S., Georgiev, H., Fritz, L. [...] Commun. 2021 , 12 , 2308, doi:10.1038/s41467-021-22589-z. Todorova, N.; Rangelov, M.; Bogoeva, V.; Stoyanova, V.; Yordanova, A.; Nikolova, G.; Georgiev, H.; Dimitrova, D.; Mohedin, S.; Stoyanova, K.; et al [...] Delord M, Viret C, Jaubert J, Liu C, Karray S, Marie JC, Irla M, Georgiev H, Clave E, Toubert A, Lucas B, Klibi J, Benlagha K. Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant

Ambulance

Carl-Neuberg-Str. 1, 30625 Hannover

Building K10, level SO

Dr. med. A. Sander; Prof. Dr. med. M. Stanulla; Dr. med. A. Partheil, Dr. med. I. Wieland

+49 511 532-3214 +49 511 532-18525 kinderonkologie.nachsorgeambulanz@mh-hannover.de

Monday - Friday from 8:00 - 16:00
(during school vacations from 08:00 - 13:00)

We offer the following diagnostic services in our oncology and follow-up consultation hours:

  • Diagnosis of leukemias, myelodysplasias and lymphomas in the event of blood count changes or lymph node swelling without significant impairment of the general condition (otherwise emergency presentation and inpatient clarification required)
  • Therapy management of oral maintenance chemotherapy or other forms of therapy after completion of intensive therapy for leukemias and solid tumors
  • Oncological follow-up care to rule out disease relapses, late effects of the disease and treatment and secondary diseases after completion of intensive chemotherapy and, if necessary, surgery/radiotherapy in accordance with the recommendations of the respective disease-specific therapy optimization study/registry.
  • Recording of neuropsychological late effects of intensive treatment including neuropsychological testing with recommendation for further diagnostics, treatment and, if necessary, support and disadvantage compensation

Range of services in the hematology outpatient clinic (diseases of the blood)

  • Deficiency of white blood cells (leukopenia) or individual subgroups of white blood cells (e.g. neutropenia, lymphocytopenia)
  • Increase in white blood cells or individual subgroups (e.g. leukemia, eosinophilia)
  • Red blood cell deficiency (anemia) due to congenital changes in haemoglobin or the erythrocyte membrane (e.g. thalassemia, sickle cell anemia, spherocythemia)
  • Bone marrow diseases with impaired formation of white and/or red blood cells and platelets
  • Immune diseases with increased breakdown of white and/or blood cells and platelets (e.g. immune eutropenia, autoimmune hemolytic anemia, immune thrombocytopenia)
  • Iron utilization disorders with chronic iron deficiency anaemia
  • Immunodeficiencies

Range of services in the coagulation outpatient clinic (blood coagulation disorders)

  • Haemophilia A or B
  • Von Willebrand syndrome (congenital and acquired)
  • Congenital or acquired deficiency of individual coagulation factors
  • Coagulation diagnostics before planned operations in cases of suspected coagulation disorders (see preoperative diagnostics below) and perioperative management of coagulation disorders (substitution treatment)
  • Platelet dysfunction (e.g. Bernard-Soulier syndrome, Glanzmann thrombasthenia, etc.)
  • Increased tendency to thrombosis (thrombophilia)
    Therapy management and diagnostics for previous thromboses (including sonographic follow-up)

 

To the outpatient clinics
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen